PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 42 filers reported holding PLX PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,191 | -24.3% | 208,998 | -4.5% | 0.05% | -71.1% |
| Q4 2022 | $35,908 | +28.2% | 218,820 | +414.8% | 0.16% | +98.8% |
| Q3 2022 | $28,000 | -76.5% | 42,509 | -13.1% | 0.08% | -63.3% |
| Q2 2022 | $119,000 | -5.6% | 48,931 | +57.1% | 0.22% | -32.7% |
| Q1 2022 | $126,000 | -56.8% | 31,150 | -14.4% | 0.32% | -80.9% |
| Q4 2021 | $292,000 | -49.9% | 36,407 | +20.6% | 1.70% | -32.5% |
| Q3 2021 | $583,000 | – | 30,186 | – | 2.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 1,875,000 | $7,575,000 | 0.41% |
| Ground Swell Capital, LLC | 31,150 | $126,000 | 0.32% |
| Park West Asset Management LLC | 1,473,218 | $5,952,000 | 0.21% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $253,000 | 0.13% |
| O'Brien Greene & Co. Inc | 60,340 | $244,000 | 0.08% |
| Eidelman Virant Capital | 27,000 | $109,000 | 0.06% |
| MBL Wealth, LLC | 52,000 | $210,000 | 0.05% |
| Shay Capital LLC | 88,620 | $358,000 | 0.05% |
| EXANE DERIVATIVES | 13,407 | $54,161,000 | 0.02% |
| GW&K Investment Management, LLC | 428,171 | $1,730,000 | 0.02% |